KalVista Pharmaceuticals Aktie
9,65
EUR
-0,05
EUR
-0,52
%
11,14
USD
-0,30
USD
-2,58
%
Werbung
KalVista Pharmaceuticals Aktie Analyse
20.03.19 | KalVista Pharmaceuticals Buy | Needham & Company, LLC | |
21.09.18 | KalVista Pharmaceuticals Overweight | Cantor Fitzgerald | |
31.08.17 | KalVista Pharmaceuticals Buy | BTIG Research |
Werbung
Werbung